Quantcast

Latest Bioniche Life Sciences Inc. Stories

2014-07-18 08:24:51

BELLEVILLE, ON, July 18, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided a key regulatory update on its flagship Phase 3 program, Mycobacterial Cell Wall-Nucleic Acid Complex (MCNA) sterile suspension for the treatment of patients with Bacillus Calmette-Guérin (BCG) refractory high grade non-muscle invasive bladder cancer. MCNA U.S. Regulatory Update Following several months of active dialogue with the U.S. Food and Drug Administration (FDA),...

2014-06-13 08:24:29

BELLEVILLE, ON, June 13, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) - ("Bioniche" or the "Company"), a clinical stage biotechnology company whose anchor product is a Phase III treatment for non-muscle-invasive bladder cancer, today announced that Dr. Michael Berendt, Chief Executive Officer and Chief Scientist of Bioniche Life Sciences Inc., will present a corporate update at the Bloom Burton & Co. Healthcare Investor Conference at the Toronto Board of Trade on...

2014-06-03 08:33:08

BELLEVILLE, ON, June 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today provided corporate updates on a number of key strategic initiatives including: -- Continued execution of Cost Reduction/Strategic Expenditures Review -- Completion of Asset Disposition Program -- Vaccine Manufacturing (VMC) Sales Process -- Urocidin(TM) Regulatory Update Strategic Expenditures Review Initiated in December 2013, management...

2014-05-14 16:29:21

(all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, May 14, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC), a clinical stage biotechnology company, today announced financial results for the third quarter of Fiscal 2014 (ended March 31, 2014). Highlights of the year-to-date include: -- Successful execution of Animal Health division sale to Vétoquinol for $61 million plus working capital adjustment; --...

2014-04-15 20:23:13

LURE, FRANCE and BELLEVILLE, ON, April 15, 2014 /PRNewswire/ - Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced the closing of the sale of Bioniche's Animal Health business to Vétoquinol. The two companies announced the signing of a share purchase agreement in February that was subject to the approval of Bioniche shareholders. At a Special Meeting of Shareholders held yesterday, 97.4% of the Shares that were voted were in...

2014-04-14 12:36:38

BELLEVILLE, ON, April 14, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that its shareholders have voted in favour of the sale of the Company's Animal Health business to Vétoquinol SA. At a Special Meeting of Shareholders held this morning in Toronto, 39.4% of the issued and outstanding shares were voted, with 97.4% of those voting in favour of the sale transaction. The transaction is expected to close tomorrow. About Bioniche Life Sciences...

2014-04-03 16:24:27

BELLEVILLE, ON, April 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that it has successfully monetized two non-core properties for net proceeds in excess of $1 million. Over the past several months, the Board of Directors and management team have developed and have been implementing a strategic expenditures review which included identifying and divesting non-core assets. The sale of the property adjacent to the Company's Belleville, Ontario...

2014-04-03 12:29:32

BELLEVILLE, ON, April 3, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today announced that Institutional Shareholder Services (ISS) has recommended that shareholders vote FOR the special resolution pertaining to the sale of all of the Corporation's Animal Health business to Vétoquinol SA, to be considered at the upcoming Special Meeting of Shareholders: Monday, April 14, 2014 9:00 .m. EST Norton Rose Fulbright Canada Board Rooms D, E, and F Royal Bank Plaza, South...

2014-03-13 20:24:06

BELLEVILLE, ON, March 13, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) today held a conference call and audio webcast for its shareholders, at which time, Company representatives provided several corporate updates. The corporate presentation used during today's call/webcast is available on the Company's website (www.Bioniche.com) under Investors - Corporate Presentations. Sale Transaction of Bioniche Animal Health to Vétoquinol The Company outlined some of the...

2014-03-04 08:33:11

BELLEVILLE, ON, March 4, 2014 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) announced today key corporate updates: -- The establishment of Monday, April 14, 2014 as the date of the Shareholder Meeting for consideration of the C$61 million acquisition offer for Bioniche's Animal Health business; -- The scheduling of a Shareholder Conference Call on Thursday, March 13, 2014, with Bioniche CEO, Dr. Michael Berendt, to...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related